@article {377, title = {Performances and Activities of Virtual Pediatrics Medication Counselling Clinic in Riyadh City, Saudi Arabia}, journal = {International Journal of Pharmacology and Clinical Sciences}, volume = {12}, year = {2023}, month = {February 2024}, pages = {189-194}, type = {Research Article}, chapter = {189}, abstract = {

Objectives: To explore the activities and performances of a virtual pediatrics medication counseling clinic in Riyadh City, Saudi Arabia. Methods: it was a retrospective analysis of activities and performances of a virtual pediatric medicine counseling clinic operated by the pharmacist at a public pediatric and maternity hospital. The pharmacist documented all the activities, including demographic information of patients visiting the clinic, the reason for the counseling, medication requirements to be counseled, and patient counseling items based on international guidelines. The data analysis was done through SPSS version 20 and Microsoft Excel version 2021; descriptive analysis and logistic regression of factors associated with the reason for counseling. Results: The total number of patients who visited the virtual pediatric medicine clinic through 20 months was 1955, with (97.75) per month. The majority of patients were female in the year 2021, 204 (63.55\%) vs. female 900 (61.19\%) in 2021, compared to male 117 (36.46\%) vs. males in year 2022 628 (38.81\%) with non-significant differences (p=0.149). The majority of patients were diagnosed as Diabetic Miletus in both years, 145 (45.17\%) vs 884 (54.47\%), with statistical significance differences between two 2021 and 2022 (p=0.000). The majority of patients counseled due to high alert medication was 230 (71.65\%) in 2021 vs. 1198 (73.32\%) in 2022, with non-statistically significant difference between them (p=0.539), and chronic diseases such as diabetes and asthma 224 (69.78\%) vs. 901 (55.14\%) in the year 2021 and 2022 respectively with statistical significance differences between both years (p=0.000). Most medication counseled was Insulin Aspart in both years, 121 (21.72\%) vs. 909 (31.92\%), insulin Glargine 104 (18.67\%) in 2021 vs. 555 (19.49\%) in 2022, and Enoxaparin in both years 40 (7.18\%) vs. 205 (7.20\%). Conclusion: The virtual pediatric medicine counseling clinic served many patients, emphasizing pediatric chronic diseases such as Diabetes and Asthma. Future studies are highly recommended to measure the clinical and economic outcomes and patient satisfaction.

}, keywords = {Clinic, Counseling, Medication, Pediatric, Saudi Arabia, Virtual}, doi = {10.5530/ijpcs.2023.12.26}, author = {Nouf Musleh Alassadi and Asma Mohammed Alzahrani and Haifa Shabeeb Almutairi and Tahani Mohammed Alotaibi and Mona Yousef Lubbad and Nouf Abdurazaq Alhaza and Raghad Maluoh Alanazi and Yousef Ahmed Alomi} } @article {197, title = {Cost Analysis of Clinical Compounding in Saudi Arabia: Antihypertensive of Pediatric Formulations}, journal = {International Journal of Pharmacology and Clinical Sciences}, volume = {8}, year = {2019}, month = {November 2019}, pages = {s2-s6}, type = {Research Article}, chapter = {s2}, abstract = {

Objectives: The primary objective of this study was to explore cost analysis of pediatric formulations in Riyadh city, Saudi Arabia. Methods: This is a retrospective study of cost analysis of pediatric formulations at 300-bed pediatric and maternity hospital in Riyadh city, Saudi Arabia. The pharmacy section of this hospital receives the specific formulation from the physician. Then, the expert pharmacist applied the international standard for clinical compounding and provides services to the healthcare staff and patients over 8 hr per day for 5 days per week. The pediatric formulations consisted of but not limited to antibiotics, anti-tuberculosis (TB) medications and anti-hypertensive medications. The cost analysis included the variable expenses such as personal cost, material cost and supply cost and fixed expenses such as direct cost, non-salary cost and overhead cost. The cost was derived from the Ministry of Health information database. All costs used have been analyzed in US dollar currency. In this study, we analyzed the cost of antihypertensive medications for pediatric use through the Microsoft Excel software (version 10). Results: The estimated average total standard cost of pediatric formulations per hour was 53.82 USD and consisted of 58.58\% (31.53 USD) for personal cost, 25.14\% (13.53 USD) for overhead cost, 3.34\% (1.8 USD) for material and supply cost and 12.93\% (6.96 USD) for the non-salary cost. The average estimated cost of Propranolol, Captopril, Methyldopa, Amlodipine and Hydralazine per each preparation was (8.27 USD, 2.37 USD, 6.88 USD, 17.385 USD) and (49.44 USD), respectively. Conclusion: To the best of our knowledge, this is the first study which demonstrated the cost analysis of antihypertensive pediatric formulation in the Kingdom of Saudi Arabia. The pediatric formulations with cost analysis can involve health insurance coverage. Targeting the cost analysis of all pediatric formulation is highly recommended to fit with Saudi vision 2030 in the Kingdom of Saudi Arabia.

}, keywords = {Analysis, Antihypertensive, Clinical, Compounding, Cost, Formulations, Pediatric, Saudi Arabia}, doi = {10.5530/ijpcs.2019.8.36}, author = {Yousef Ahmed Alomi and Fatimah Fouad Al Doughan and Faiz A. Bahadig and Malika Alhadab and Mona Lubbad and Ebtesam Nazal} }